Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Treasury Shares (2020 - 2024)

Historic Treasury Shares for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q4 2024 value amounting to $7.9 million.

  • Maravai Lifesciences Holdings' Treasury Shares rose 10147.06% to $7.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.9 million, marking a year-over-year increase of 10147.06%. This contributed to the annual value of $7.9 million for FY2024, which is 10147.06% up from last year.
  • As of Q4 2024, Maravai Lifesciences Holdings' Treasury Shares stood at $7.9 million, which was up 10147.06% from $3.9 million recorded in Q4 2023.
  • Maravai Lifesciences Holdings' 5-year Treasury Shares high stood at $7.9 million for Q4 2024, and its period low was $159000.0 during Q4 2021.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Treasury Shares value was $1.4 million (recorded in 2020), while the average stood at $2.5 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Treasury Shares plummeted by 5444.13% in 2021 and then soared by 73710.69% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Treasury Shares (Quarter) stood at $349000.0 in 2020, then tumbled by 54.44% to $159000.0 in 2021, then surged by 737.11% to $1.3 million in 2022, then surged by 196.32% to $3.9 million in 2023, then soared by 101.47% to $7.9 million in 2024.
  • Its Treasury Shares stands at $7.9 million for Q4 2024, versus $3.9 million for Q4 2023 and $1.3 million for Q4 2022.